Hamza Suria - 12 May 2021 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role: President, CEO, Director
Signature: /s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol: ANAB
Transactions as of: 12 May 2021
Net transactions value: +$11,200
Form type: 4
Filing time: 13 May 2021, 16:50:29 UTC
Next filing: 21 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANAB	Common Stock	Options Exercise	$11,200	+10,000	+21%	$1.12^*	57,636	12 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANAB	Employee Stock Option (right to buy)	Options Exercise	$0	-10,000	-25%	$0.000000	30,361	12 May 2021	Common Stock	10,000	$1.12	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option is fully vested and immediately exercisable.
F2	In addition to the remaining options to purchase 30,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 57,636 shares of common stock held directly.